S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|pSivida to Present At Two Investment Conferences in September ()|
|pSivida Corp. Announces Fourth Quarter and Fiscal Year 2013 Financial Results Release Date and Conference Call Information (2013/9/18)|
|pSivida to Present at 4th Annual Conference on Biosimilars & Biobetters (2013/9/27)|
|pSivida Corp. Reports Fourth Quarter and Fiscal Year 2013 Results (2013/9/25)|
|pSivida Announces That U.K.’s NICE Recommends ILUVIEN® for Chronic Diabetic Macular Edema in Pseudophakic Eyes; NHS Reimbursement Expected to Follow (2013/9/30)|
|pSivida Reports Complete Response Letter From FDA for ILUVIEN® (2013/10/18)|
|pSivida Corp Announces First Quarter 2014 Financial Results Release Date and Conference Call Information (2013/11/5)|
|pSivida Corp. Reports First Quarter 2014 Results (2013/11/12)|
|pSivida Reports ILUVIEN® to Be Funded by UK’s National Health Service for Treatment of Pseudophakic Chronic DME Patients Following Issuance of Final NICE Guidance (2013/12/2)|
|U.S. Hot Stocks Futures: Hot Stocks to Watch ()|
Click above to view more mutual fund data and stats for psdv - pSivida Ltd..